The classical vs nonclassical NSAIDs: can the reduction in pain overcome the thrombotic risk?

摘要

The advent of cyclooxygenase-2 inhibitors has been both a blessing and a curse for pain management. An in-depth understanding of the biological molecules in the arachidonic acid metabolism may alleviate pain without risk.